We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil
‹ An tOrd Gnó - Order of Business

SkyClarys reimbursement

Summary

Ken O’Flynn asks why SkyClarys is not reimbursed for children with Friedreich’s ataxia. The Taoiseach says reimbursement follows a statutory process and an unfavourable health-technology assessment, but will continue discussing the case with the Health Minister.

In my constituency a family have already buried one child due to Friedreich's ataxia and their second child is now in a wheelchair due to the same disease, which is advancing. A treatment called SkyClarys is clinically approved and has been shown to slow the progress and the State refuses to reimburse it. Let me be clear: this is not about science or availability; this is about a decision not to fund. What does the Taoiseach say to parents watching their child's disease progress in real time while a treatment exists but is withheld? I want to ask him a direct question. Will he instruct the Minister for Health to fast-track a reimbursement decision for SkyClarys and define the timeframe? Yes or no.

Comment on this

First, it is not a simple decision not to fund. That is not a fair way of putting it. I have spoken to the Minister for Health on this issue. As the Deputy knows, there is a legislative framework governing the reimbursement of medicines, particularly for rare conditions. This is a very sad case with very difficult circumstances for the family. I have spoken to the Minister and I will continue to engage with her this week. I cannot promise anything today. The health technology assessment was not positive in terms of how they do their work. It is an area on which I will come back to the Deputy.

Comment on this